United States Biotechnology & Medical Research

Neurocrine Biosciences Inc (NBIX)

Track

Over the past 90 days, Neurocrine Biosciences Inc. insiders have executed 43 transactions, all of which were sales totaling approximately $132.3 million. Key executives, including the Chief Regulatory Officer and Chief Legal Officer, conducted these planned sales. These activities occurred alongside a 6.1% stock price increase and a positive earnings report.
Ticker: NBIX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Neurocrine Biosciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 28 Jul 2026
Value US$2,318,487.33 | Price 444.38 | Shares 95,323 (+46.6%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-30 2026-07-28 PlS Planned sale
Norwalk Leslie V
Non-Executive Director
95,323 +46.6%
444.38
US$2,318,487 		95,323 +46.6% 444.38 US$2,318,487
2026-07-13 2026-07-10 PlS Planned sale
Delaet Ingrid

Chief Regulatory Officer

Officer
55,575 +47.1%
97.43
US$1,965,696 		55,575 +47.1% 97.43 US$1,965,696
2026-07-10 2026-07-10 PrS Proposed sale
INGRID DELAET

Officer

Officer
93,260
406.78
US$1,828,038 		93,260 406.78 US$1,828,038
2026-07-13 2026-07-09 PlS Planned sale
Lippoldt Darin

Chief Legal Officer

Officer
10,000 -15.4%
179.60
US$1,796,014 		10,000 -15.4% 179.60 US$1,796,014
2026-07-09 2026-07-09 PlS Planned sale
Delaet Ingrid

Chief Regulatory Officer

Officer
8,433 -34.2%
178.72
US$1,507,135 		8,433 -34.2% 178.72 US$1,507,135
2026-07-09 2026-07-09 PrS Proposed sale
DARIN LIPPOLDT

Officer

Officer
10,000
178.24
US$1,782,400 		10,000 178.24 US$1,782,400
2026-07-09 2026-07-08 PlS Planned sale
Delaet Ingrid

Chief Regulatory Officer

Officer
2,737 -14.4%
178.54
US$488,672 		2,737 -14.4% 178.54 US$488,672
2026-07-09 2026-07-07 PlS Planned sale
Delaet Ingrid

Chief Regulatory Officer

Officer
3,401 -17.3%
178.57
US$607,305 		3,401 -17.3% 178.57 US$607,305
2026-07-07 2026-07-07 PrS Proposed sale
INGRID DELAET

Officer

Officer
14,571
174.10
US$2,536,811 		14,571 174.10 US$2,536,811
2026-06-30 2026-06-29 PlS Planned sale
Lippoldt Darin

Chief Legal Officer

Officer
1,690 -3.0%
170.81
US$288,676 		1,690 -3.0% 170.81 US$288,676
2026-06-30 2026-06-29 PlS Planned sale
Lippoldt Darin

Chief Legal Officer

Officer
8,110 -12.9%
170.03
US$1,378,903 		8,110 -12.9% 170.03 US$1,378,903
2026-06-29 2026-06-29 PrS Proposed sale
DARIN LIPPOLDT

Officer

Officer
9,800
168.52
US$1,651,496 		9,800 168.52 US$1,651,496
2026-06-30 2026-06-26 PlS Planned sale
Lippoldt Darin

Chief Legal Officer

Officer
200 -0.4%
169.57
US$33,913 		200 -0.4% 169.57 US$33,913
2026-06-26 2026-06-26 PrS Proposed sale
DARIN LIPPOLDT

Officer

Officer
200
164.18
US$32,836 		200 164.18 US$32,836
2026-06-09 2026-06-05 PlS Planned sale
3.1
SHERWIN STEPHEN A
Non-Executive Director
1,843 -10.4%
167.31
US$308,357 		1,843 -10.4% 167.31 US$308,357
2026-06-09 2026-06-05 PlS Planned sale
3.1
SHERWIN STEPHEN A
Non-Executive Director
5,829 -24.8%
166.56
US$970,859 		5,829 -24.8% 166.56 US$970,859
2026-06-09 2026-06-05 PlS Planned sale
3.1
SHERWIN STEPHEN A
Non-Executive Director
6,896 -22.7%
165.79
US$1,143,306 		6,896 -22.7% 165.79 US$1,143,306
2026-06-09 2026-06-05 PlS Planned sale
3.1
SHERWIN STEPHEN A
Non-Executive Director
2,549 -7.7%
164.44
US$419,156 		2,549 -7.7% 164.44 US$419,156
2026-06-09 2026-06-05 PlS Planned sale
3.1
SHERWIN STEPHEN A
Non-Executive Director
7,883 -19.3%
163.81
US$1,291,291 		7,883 -19.3% 163.81 US$1,291,291
2026-06-05 2026-06-05 PrS Proposed sale
3.1
STEPHEN SHERWIN

Director

Non-Executive Director
25,000
167.35
US$4,183,750 		25,000 167.35 US$4,183,750
2026-06-05 2026-06-05 PrS Proposed sale
3.1
STEPHEN SHERWIN

Director

Non-Executive Director
25,000
167.35
US$4,183,750 		25,000 167.35 US$4,183,750
2026-06-08 2026-06-04 PlS Planned sale
Norwalk Leslie V
Non-Executive Director
1,250 -30.6%
168.06
US$210,072 		1,250 -30.6% 168.06 US$210,072
2026-06-04 2026-06-02 PlS Planned sale
Cooke Julie

Chief Human Resources Officer

Officer
3,520 -13.6%
158.59
US$558,236 		3,520 -13.6% 158.59 US$558,236
2026-06-04 2026-06-02 PlS Planned sale
Cooke Julie

Chief Human Resources Officer

Officer
9,521 -26.9%
157.62
US$1,500,663 		9,521 -26.9% 157.62 US$1,500,663
2026-06-04 2026-06-02 PlS Planned sale
Cooke Julie

Chief Human Resources Officer

Officer
4,216 -10.6%
156.77
US$660,925 		4,216 -10.6% 156.77 US$660,925
2026-06-04 2026-06-02 PlS Planned sale
Cooke Julie

Chief Human Resources Officer

Officer
5,466 -12.1%
155.46
US$849,726 		5,466 -12.1% 155.46 US$849,726
2026-06-04 2026-06-02 PlS Planned sale
Cooke Julie

Chief Human Resources Officer

Officer
14,214 -24.0%
154.83
US$2,200,685 		14,214 -24.0% 154.83 US$2,200,685
2026-06-02 2026-06-02 PrS Proposed sale
JULIE COOKE

Officer

Officer
36,937
161.00
US$5,946,857 		36,937 161.00 US$5,946,857
2026-06-02 2026-06-01 PlS Planned sale
3.4
Onyia Jude

Chief Scientific Officer

Officer
11,000 -29.9%
160.25
US$1,762,710 		11,000 -29.9% 160.25 US$1,762,710
2026-06-01 2026-06-01 PrS Proposed sale
3.4
JUDE ONYIA

Officer

Officer
11,000
158.30
US$1,741,300 		11,000 158.30 US$1,741,300
2026-06-02 2026-05-29 PlS Planned sale
Delaet Ingrid

Chief Regulatory Officer

Officer
2,261 -12.2%
156.71
US$354,321 		2,261 -12.2% 156.71 US$354,321
2026-05-29 2026-05-29 PrS Proposed sale
INGRID DELAET

Officer

Officer
2,261
156.39
US$353,598 		2,261 156.39 US$353,598
2026-05-29 2026-05-27 PlS Planned sale
3.4
Onyia Jude

Chief Scientific Officer

Officer
11,000 -29.9%
155.53
US$1,710,865 		11,000 -29.9% 155.53 US$1,710,865
2026-05-27 2026-05-27 PrS Proposed sale
3.4
JUDE ONYIA

Officer

Officer
11,000
155.73
US$1,713,030 		11,000 155.73 US$1,713,030
2026-05-28 2026-05-26 PlS Planned sale
Boyer David W.

Chief Corp. Affairs Officer

Officer
3,888 -33.3%
156.64
US$609,023 		3,888 -33.3% 156.64 US$609,023
2026-05-26 2026-05-26 PrS Proposed sale
DAVID WARREN BOYER

Officer

Officer
3,888
156.70
US$609,250 		3,888 156.70 US$609,250
2026-05-21 2026-05-19 PlS Planned sale
3.1
GORMAN KEVIN CHARLES
Non-Executive Director
245,088 -32.4%
154.33
US$37,824,872 		245,088 -32.4% 154.33 US$37,824,872
2026-05-19 2026-05-19 PrS Proposed sale
3.1
KEVIN CHARLES GORMAN

Director

Non-Executive Director
245,088
157.21
US$38,530,284 		245,088 157.21 US$38,530,284
2026-05-18 2026-05-15 PlS Planned sale
2.7
POPS RICHARD F
Non-Executive Director
15,000 -30.3%
157.65
US$2,364,760 		15,000 -30.3% 157.65 US$2,364,760
2026-05-15 2026-05-15 PrS Proposed sale
2.7
RICHARD F POPS

Director

Non-Executive Director
15,000
159.05
US$2,385,750 		15,000 159.05 US$2,385,750
2026-05-15 2026-05-15 PrS Proposed sale
2.7
RICHARD F POPS

Director

Non-Executive Director
15,000
159.05
US$2,385,750 		15,000 159.05 US$2,385,750
2026-05-14 2026-05-12 PlS Planned sale
Norwalk Leslie V
Non-Executive Director
3,810 -61.1%
155.01
US$590,601 		3,810 -61.1% 155.01 US$590,601
2026-05-12 2026-05-12 PrS Proposed sale
Norwalk Leslie V

Director

Non-Executive Director
6,310
162.92
US$1,028,050 		6,310 162.92 US$1,028,050
2026-01-20 2026-01-16 PlS Planned sale
Gano Kyle

Chief Executive Officer

Executive Director
1,812 -1.3%
132.71
US$240,478 		1,812 -1.3% 132.71 US$240,478
2026-01-20 2026-01-16 PlS Planned sale
Gano Kyle

Chief Executive Officer

Executive Director
34,588 -19.8%
132.70
US$4,589,980 		34,588 -19.8% 132.70 US$4,589,980
2026-01-16 2026-01-16 PrS Proposed sale
KYLE GANO

Officer

Officer
36,400
133.35
US$4,853,940 		36,400 133.35 US$4,853,940
2025-12-17 2025-12-16 PlS Planned sale
Norwalk Leslie V
Non-Executive Director
1,190 -16.0%
155.09
US$184,558 		1,190 -16.0% 155.09 US$184,558
2025-12-17 2025-12-15 PlS Planned sale
Norwalk Leslie V
Non-Executive Director
5,000 -40.2%
152.23
US$761,144 		5,000 -40.2% 152.23 US$761,144
2025-12-15 2025-12-15 PrS Proposed sale
Norwalk Leslie V

Director

Non-Executive Director
11,250
155.11
US$1,745,000 		11,250 155.11 US$1,745,000
2025-12-10 2025-12-08 PlS Planned sale
Lippoldt Darin

Chief Legal Officer

Officer
4,376 -9.2%
159.65
US$698,615 		4,376 -9.2% 159.65 US$698,615
2025-12-08 2025-12-08 PrS Proposed sale
DARIN LIPPOLDT

Officer

Officer
4,376
155.51
US$680,512 		4,376 155.51 US$680,512
2025-12-04 2025-12-03 PlS Planned sale
2.2
LYONS GARY A
Non-Executive Director
15,000 -11.1%
152.61
US$2,289,082 		15,000 -11.1% 152.61 US$2,289,082
2025-12-03 2025-12-03 PrS Proposed sale
2.2
GARY A LYONS REVOCABLE LIVING U/A DTD 06/08/2012

Director

Non-Executive Director
15,000
152.48
US$2,287,200 		15,000 152.48 US$2,287,200
2025-12-02 2025-11-28 PlS Planned sale
BENEVICH ERIC

Chief Commercial Officer

Officer
5,970 -11.7%
151.74
US$905,881 		5,970 -11.7% 151.74 US$905,881
2025-11-28 2025-11-28 PrS Proposed sale
ERIC BENEVICH

Officer

Officer
5,970
151.58
US$904,933 		5,970 151.58 US$904,933
2025-11-26 2025-11-25 PlS Planned sale
2.8
MORROW GEORGE J
Non-Executive Director
15,000 -68.0%
143.37
US$2,150,512 		15,000 -68.0% 143.37 US$2,150,512
2025-11-25 2025-11-25 PrS Proposed sale
2.8
GEORGE MORROW

Director

Non-Executive Director
15,000
141.25
US$2,118,750 		15,000 141.25 US$2,118,750
2025-11-06 2025-11-05 PlS Planned sale
3.0
RASTETTER WILLIAM H
Non-Executive Director
18,000 -30.8%
151.82
US$2,732,690 		18,000 -30.8% 151.82 US$2,732,690
2025-11-05 2025-11-05 PrS Proposed sale
3.0
WILLIAM H. RASTETTER

Director

Non-Executive Director
18,000
143.19
US$2,577,420 		18,000 143.19 US$2,577,420
2025-11-05 2025-11-04 PrS Proposed sale
Gano Kyle

Officer; Director

Executive Director
300
141.97
US$42,591 		300 141.97 US$42,591
2025-11-04 2025-11-04 PlS Planned sale
Gano Kyle

Chief Executive Officer

Executive Director
300 -0.2%
141.97
US$42,591 		300 -0.2% 141.97 US$42,591
2025-08-11 2025-08-07 PlS Planned sale
3.1
GORMAN KEVIN CHARLES
Non-Executive Director
106,322 -17.1%
126.41
US$13,440,281 		106,322 -17.1% 126.41 US$13,440,281
2025-08-07 2025-08-07 PrS Proposed sale
3.1
KEVIN CHARLES GORMAN

Director

Non-Executive Director
106,322
128.43
US$13,654,934 		106,322 128.43 US$13,654,934
2025-07-11 2025-07-10 PlS Planned sale
Delaet Ingrid

Chief Regulatory Officer

Officer
457 -8.8%
135.00
US$61,695 		457 -8.8% 135.00 US$61,695
2025-07-10 2025-07-10 PrS Proposed sale
INGRID DELAET

Officer

Officer
457
133.51
US$61,014 		457 133.51 US$61,014
2025-07-11 2025-07-09 PlS Planned sale
3.4
Onyia Jude

Chief Scientific Officer

Officer
59,819 -76.6%
130.46
US$7,803,688 		59,819 -76.6% 130.46 US$7,803,688
2025-07-07 2025-07-02 PlS Planned sale
3.4
Onyia Jude

Chief Scientific Officer

Officer
20,362 -52.7%
130.13
US$2,649,738 		20,362 -52.7% 130.13 US$2,649,738
2025-07-02 2025-07-02 PrS Proposed sale
3.4
JUDE ONYIA

Officer

Officer
80,181
128.00
US$10,263,168 		80,181 128.00 US$10,263,168
2025-05-29 2025-05-27 PlS Planned sale
3.1
GORMAN KEVIN CHARLES
Non-Executive Director
9,613 -1.8%
120.38
US$1,157,211 		9,613 -1.8% 120.38 US$1,157,211
2025-05-27 2025-05-27 PrS Proposed sale
3.1
KEVIN CHARLES GORMAN

Director

Non-Executive Director
9,613
120.18
US$1,155,290 		9,613 120.18 US$1,155,290
2025-05-07 2025-05-05 PlS Planned sale
3.0
RASTETTER WILLIAM H
Non-Executive Director
30,000 -44.5%
110.20
US$3,305,952 		30,000 -44.5% 110.20 US$3,305,952
2025-05-05 2025-05-05 PrS Proposed sale
3.0
WILLIAM H. RASTETTER

Officer

Officer
30,000
109.68
US$3,290,400 		30,000 109.68 US$3,290,400
2025-02-14 2025-02-14 PrS Proposed sale
1.6
EIRY WYN ROBERTS

Officer

Officer
500
115.04
US$57,521 		500 115.04 US$57,521
2025-02-14 2025-02-14 S Sale
1.6
ROBERTS EIRY

Chief Medical Officer

Officer
500 -1.4%
115.04
US$57,521 		500 -1.4% 115.04 US$57,521
2025-02-14 2025-02-13 PlS Planned sale
Cooke Julie

Chief Human Resources Officer

Officer
755 -3.6%
116.80
US$88,183 		755 -3.6% 116.80 US$88,183
Explore more

More insider trading research around Neurocrine Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America